X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/invagen-pharmaceuticals-issues-voluntary-nationwide-recall-vigabatrin-oral-solution-usp-500mg-due
https://www.fiercepharma.com/manufacturing/cipla-unit-recalls-one-lot-anti-seizure-drug-due-packaging-problem
https://www.prnewswire.com/news-releases/invagen-pharmaceuticals-issues-voluntary-nationwide-recall-of-vigabatrin-for-oral-solution-usp-500mg-due-to-leaking-sachets-302010708.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208200
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200432
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-15-2021-1639544435.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214957
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215414
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213293
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208200
Market Place
Share 
